biotech returns
host.cnbc.com
Hit stop after the graphic loads, hitting stop
prevents a bad advertisement from loading.
Looks like the list is incomplete.
Noticed Peter's Celgene up there with the
silver medal, three year return.
Gilder subthread of the Valuation board--I'd point
to Ariad too, maybe they will slow down adding
acronyms and partner one of them soon?
No position in Ariad for some time.
patents and algorithms--
Better mousetrap, better drug, still have
to get it to market. I haven't seen this
"disruption" thrown around on the biotech
threads before now, same as "discontinuous
innovation". Well if the drug works, or
works better than the competition, good
enough, K.I.S.S. right?
............
Rick--Miriel looked up at me today and very clearly
said Ma Ma.
Whew, Bay area traffic was exausting, hit me today.
Was fun to check the five day charts and see all
the great trades I would have made, ha.
RWR--yes, rabid! Cadus is largest position,
but no shares trading hands, weird. Some of
the discount in case of taxable distribution (?)
would not hurt me...but not spending my cash hoard
on more. In fact, splitting up brokerage account
into thirds, tucking cash away here and there.
Starting over with a chunk for trading. Also
looking at some things outside the biotech sector,
but doing that with more of a full-service broker,
and going very slowly, that account will not be for
trading, may work, may not--heck, the discount churn
and burn was actually pretty expensive--at least
a couple of percent in commissions. Of course when
you are up 7x you end up giving plenty of $20s away.
Those days are over.
Am keeping KDUS, SNAP, CNSI and a little TGEN.
Scrapped lots of things that are interesting,
and wont look back unless the sector corrects
again, I wanted to keep VLTS and TRGNY,
but it will be enough for me to follow Tgen,
maybe add some on dips, there are always dips.
Patience, fewer trades and smarter choices will
take me the rest of the way to where I want to be. |
